Life sciences news
-
Bone Therapeutics to broaden and derisk therapeutic portfolio by acquiring majority participation in Medsenic
Wednesday August 10th 2022
Read more
-
Mayne Pharma and Mithra announce FDA approval of HALOETTE®, a generic version of NUVARING®
Monday August 8th 2022
Read more
-
S-Biomedic welcomes Pascal Yvon to lead its B2B commercial activities
Tuesday August 2nd 2022
Read more
-
Celyad Oncology announces FDA lifts clinical hold of CYAD-101-002 Phase 1b trial
Monday August 1st 2022
Read more
-
NEXTSTELLIS® oral contraceptive now available in Australia
Tuesday July 26th 2022
Read more
-
Precirix and Eckert & Ziegler sign agreement on priority supply of the therapeutic radioisotope Actinium-225
Tuesday July 26th 2022
Read more
-
Sequana Medical secures EUR 10 million loan facility with Kreos Capital
Wednesday July 20th 2022
Read more
-
Sequana Medical completes enrollment in Phase 2a SAHARA I DSR study and reports disease-modifying profile for Short Term DSR
Tuesday July 19th 2022
Read more
-
Become a flanders.bio member
Your news here?
-
Agomab raises additional $40.5 million through Series B extension bringing total amount to $114 million
Wednesday July 13th 2022
Read more
-
ANeuroTech receives positive feedback from the FDA for its pivotal Phase IIIb development programme for ANT-01 as an adjunctive anti-depression drug for Major Depressive Disorder
Tuesday July 5th 2022
Read more
-
Confo Therapeutics awarded EUR 1.7M VLAIO grant to expand application of ConfoBody® drug discovery and development technology in rare diseases
Tuesday June 28th 2022
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
